Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

May 2019

BMJ updates its Tamiflu campaign page

The BMJ’s first open data campaign aimed to pressure companies into releasing the underlying clinical trial data for two globally stockpiled anti-influenza drugs, Tamiflu and Relenza. The campaign lasted nearly four years and was ultimately successful, and helped galvanize a movement towards increased transparency of clinical trial data.